Table 1.
Variable | Group Z (n = 17) | Group J (n = 51) | p-value |
---|---|---|---|
Age (range) | 75.2 ± 3.94 (69–84) | 75.3 ± 5.34 (61–85) | 0.912 |
Male(%)/Female(%) | 16(94%)/1 (6%) | 46(90%)/5 (10%) | 0.885 |
Diabetes mellitus | 3 (17.6%) | 12 (23.5%) | 0.880 |
Chronic kidney disease | 6 (35.3%) | 14 (27.5%) | 0.828 |
COPD | 5 (29.4%) | 23 (45.1%) | 0.523 |
Coronary artery disease | 4 (23.5%) | 13 (25.5%) | 0.987 |
Aortic operation | 4 (23.5%) | 9 (17.6%) | 0.867 |
Cerebral vascular disease | 2 (11.8%) | 10 (19.6%) | 0.764 |
Peripheral artery disease | 3 (17.6%) | 7 (13.7%) | 0.925 |
Poor LVEF (<50%) | 2 (11.8%) | 3 (5.9%) | 0.723 |
Aneurysm diameter (mm) (range) | 57.3 ± 8.8 (42–70) | 57.9 ± 9.7 (35–89) | 0.859 |
Aneurysm type, saccular/fusiform | 16 (94%)/1 (6%) | 43 (86%)/8 (14%) | 0.586 |
Length of aneurysm (mm) (from SCA to the end of aneurysm) | 72.5 ± 22.0 | 72.8 ± 20.7 | 0.883 |
COPD: chronic obstructive pulmonary disease; LVEF: left ventricular ejection fraction.